Biopolym. Cell. 1998; 14(6):477-487.
http://dx.doi.org/10.7124/bc.0004EF
Огляди
Антисенсові РНК як засіб регуляції експресії генів
1Кухаренко О. П., 1Швед А. Д.
  1. Інститут молекулярної біології і генетики НАН України
    Вул. Академіка Заболотного, 150, Київ, Україна, 03680

Abstract

В огляді на прикладах багатьох досліджень розглянуто проблеми регуляції експресії генів за допомогою антисенсових РНК у прокаріотах та в еукаріотичних клітинах. Знані у увагу приділене проблемі створення внутрішньоклітинної резистентності проти вірусів з використанням анти­сенсових РНК Аналізуються загальна концепція та стратегія побудови штучних систем антисенсової регуляції експресії генів у клітинах еукаріот.
Повний текст: (PDF, англійською)

References

[1] Zamecnik PC, Stephenson ML. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci U S A. 1978;75(1):280-4.
[2] Stephenson ML, Zamecnik PC. Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc Natl Acad Sci U S A. 1978;75(1):285-8.
[3] Stein CA, Cheng YC. Antisense oligonucleotides as therapeutic agents--is the bullet really magical? Science. 1993;261(5124):1004-12.
[4] Matsukura M, Shinozuka K, Zon G, Mitsuya H, Reitz M, Cohen JS, Broder S. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc Natl Acad Sci U S A. 1987;84(21):7706-10.
[5] Zamecnik PC, Goodchild J, Taguchi Y, Sarin PS. Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proc Natl Acad Sci U S A. 1986;83(12):4143-6.
[6] Izant JG, Weintraub H. Inhibition of thymidine kinase gene expression by anti-sense RNA: a molecular approach to genetic analysis. Cell. 1984;36(4):1007-15.
[7] Izant JG, Weintraub H. Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA. Science. 1985;229(4711):345-52.
[8] Tomizawa J, Itoh T, Selzer G, Som T. Inhibition of ColE1 RNA primer formation by a plasmid-specified small RNA. Proc Natl Acad Sci U S A. 1981;78(3):1421-5.
[9] Light J, Molin S. The sites of action of the two copy number control functions of plasmid R1. Mol Gen Genet. 1982;187(3):486-93.
[10] Simons RW, Kleckner N. Translational control of IS10 transposition. Cell. 1983;34(2):683-91.
[11] Tomizawa J, Som T. Control of ColE1 plasmid replication: enhancement of binding of RNA I to the primer transcript by the Rom protein. Cell. 1984;38(3):871-8.
[12] Kim SK, Wold BJ. Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNA. Cell. 1985;42(1):129-38.
[13] Preiss A, Rosenberg UB, Kienlin A, Seifert E, J?ckle H. Molecular genetics of Kr?ppel, a gene required for segmentation of the Drosophila embryo. Nature. 1985 Jan 3-9;313(5997):27-32.
[14] Crowley TE, Nellen W, Gomer RH, Firtel RA. Phenocopy of discoidin I-minus mutants by antisense transformation in Dictyostelium. Cell. 1985;43(3 Pt 2):633-41.
[15] Farnham PJ, Abrams JM, Schimke RT. Opposite-strand RNAs from the 5' flanking region of the mouse dihydrofolate reductase gene. Proc Natl Acad Sci U S A. 1985;82(12):3978-82.
[16] Celano P, Craig M. Characterization of a naturally occuring antisense RNA transcript with homology to the second intron of the human c-myc gene. J Cell Biochem. 1991; Suppl. 15D:13.
[17] Boal T, Cohen R, Noguchi M. Identification of potential antisense regulation of eIF-2a gene expression. J Cell Biochem. 1991; Suppl. 15D:15.
[18] Tomizawa J. Control of ColE1 plasmid replication: initial interaction of RNA I and the primer transcript is reversible. Cell. 1985;40(3):527-35.
[19] Mizuno T, Chou MY, Inouye M. A comparative study on the genes for three porins of the Escherichia coli outer membrane. DNA sequence of the osmoregulated ompC gene. J Biol Chem. 1983;258(11):6932-40.
[20] Mizuno T, Chou MY, Inouye M. A unique mechanism regulating gene expression: translational inhibition by a complementary RNA transcript (micRNA). Proc Natl Acad Sci U S A. 1984;81(7):1966-70.
[21] Khochbin S, Lawrence JJ. An antisense RNA involved in p53 mRNA maturation in murine erythroleukemia cells induced to differentiate. EMBO J. 1989;8(13):4107-14.
[22] Tosic M, Roach A, de Rivaz JC, Dolivo M, Matthieu JM. Post-transcriptional events are responsible for low expression of myelin basic protein in myelin deficient mice: role of natural antisense RNA. EMBO J. 1990;9(2):401-6.
[23] Michael NL, Vahey MT, d'Arcy L, Ehrenberg PK, Mosca JD, Rappaport J, Redfield RR. Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat. J Virol. 1994;68(2):979-87.
[24] Lai PK, Barsov EV, Nonoyama M. Detection of leftward transcripts of HIV-1 in infected cells. IXth Int. Conf. on AIDS: Abstrs. Berlin, 1993. PO-A05-0078.
[25] Ch'ng JL, Mulligan RC, Schimmel P, Holmes EW. Antisense RNA complementary to 3' coding and noncoding sequences of creatine kinase is a potent inhibitor of translation in vivo. Proc Natl Acad Sci U S A. 1989;86(24):10006-10.
[26] McGarry TJ, Lindquist S. Inhibition of heat shock protein synthesis by heat-inducible antisense RNA. Proc Natl Acad Sci U S A. 1986;83(2):399-403.
[27] Coleman J, Hirashima A, Inokuchi Y, Green PJ, Inouye M. A novel immune system against bacteriophage infection using complementary RNA (micRNA). Nature. 1985 Jun 13-19;315(6020):601-3.
[28] Hirashima A, Sawaki S, Inokuchi Y, Inouye M. Engineering of the mRNA-interfering complementary RNA immune system against viral infection. Proc Natl Acad Sci U S A. 1986;83(20):7726-30.
[29] Hemenway C, Fang RX, Kaniewski WK, Chua NH, Tumer NE. Analysis of the mechanism of protection in transgenic plants expressing the potato virus X coat protein or its antisense RNA. EMBO J. 1988;7(5):1273-80.
[30] Powell PA, Stark DM, Sanders PR, Beachy RN. Protection against tobacco mosaic virus in transgenic plants that express tobacco mosaic virus antisense RNA. Proc Natl Acad Sci U S A. 1989;86(18):6949-52.
[31] Chang LJ, Stoltzfus CM. Gene expression from both intronless and intron-containing Rous sarcoma virus clones is specifically inhibited by anti-sense RNA. Mol Cell Biol. 1985;5(9):2341-8.
[32] To RY, Booth SC, Neiman PE. Inhibition of retroviral replication by anti-sense RNA. Mol Cell Biol. 1986;6(12):4758-62.
[33] Neiman PE, Booth SC, To RYL. Antisense inhibition of viral replication and host-cell gene expression in avian retroviral systems. Current Communications in Molecul Biology: Antisense RNA and DNA. Ed. D. A. Melton. New York.: Cold Spring Harbor Lab., 1988: 125-8.
[34] To RYL, Neiman PE. Inhibition of replication of avian retroviruses by antisense RNA. J Cell Biochem. 1991;Suppl. 15D:11.
[35] von R?den T, Gilboa E. Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA. J Virol. 1989;63(2):677-82.
[36] Sullenger BA, Lee TC, Smith CA, Ungers GE, Gilboa E. Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication. Mol Cell Biol. 1990;10(12):6512-23.
[37] Tomsons VP, Chernobayeva LG, Kozireva SI, Konicheva VV, Peregoudova YY, Murovska MF, Tikhomirova LP. An expression of specific RNA in cell cultures with an integrated asRNA genome and their possible correlation with the repression of the BLV reproduction. Biopolym Cell. 1993; 9(4):59-62.
[38] Borisenko AS, Shaiakhmetov DM, Gerzilova AG, Tikhonenko TI. Use of U3 promotor from the LTR region of bovine leukemia virus for expressing genes for antiviral antisense RNAs in cell cultures. Mol Gen Mikrobiol Virusol. 1994;(3):16-20.
[39] Dal Monte P, Bessia C, Ripalti A, Landini MP, Topilko A, Plachter B, Virelizier JL, Michelson S. Stably expressed antisense RNA to cytomegalovirus UL83 inhibits viral replication. J Virol. 1996;70(4):2086-94.
[40] Liu Z, Batt DB, Carmichael GG. Targeted nuclear antisense RNA mimics natural antisense-induced degradation of polyoma virus early RNA. Proc Natl Acad Sci U S A. 1994;91(10):4258-62.
[41] Olson KE, Higgs S, Gaines PJ, Powers AM, Davis BS, Kamrud KI, Carlson JO, Blair CD, Beaty BJ. Genetically engineered resistance to dengue-2 virus transmission in mosquitoes. Science. 1996;272(5263):884-6.
[42] Sczakiel G, Pawlita M. Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J Virol. 1991;65(1):468-72.
[43] Sczakiel G, Pawlita M, Kleinheinz A. Specific inhibition of human immunodeficiency virus type 1 replication by RNA transcribed in sense and antisense orientation from the 5'-leader/gag region. Biochem Biophys Res Commun. 1990;169(2):643-51.
[44] Joshi S, Van Brunschot A, Asad S, van der Elst I, Read SE, Bernstein A. Inhibition of human immunodeficiency virus type 1 multiplication by antisense and sense RNA expression. J Virol. 1991;65(10):5524-30.
[45] Rittner K, Sczakiel G. Identification and analysis of antisense RNA target regions of the human immunodeficiency virus type 1. Nucleic Acids Res. 1991;19(7):1421-6.
[46] Lo KM, Biasolo MA, Dehni G, Pal? G, Haseltine WA. Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA. Virology. 1992;190(1):176-83.
[47] Chatterjee S, Johnson PR, Wong KK Jr. Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector. Science. 1992;258(5087):1485-8.
[48] Kukharenko OP, Shved AD, Rybalko LS. et al. Creating a model vector expressed antisense RNA against HIV-1 intracellular immunization for hematopoietic cells. Infekt Khvoroby. 1996; 2(3): 22-25.
[49] Sczakiel G, Homann M, Rittner K. Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1. Antisense Res Dev. 1993 Spring;3(1):45-52.
[50] Rittner K, Burmester C, Sczakiel G. In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1. Nucleic Acids Res. 1993;21(6):1381-7.
[51] Homann M, Rittner K, Sczakiel G. Complementary large loops determine the rate of RNA duplex formation in vitro in the case of an effective antisense RNA directed against the human immunodeficiency virus type 1. J Mol Biol. 1993;233(1):7-15.
[52] Hjalt TA, Wagner EG. Bulged-out nucleotides in an antisense RNA are required for rapid target RNA binding in vitro and inhibition in vivo. Nucleic Acids Res. 1995;23(4):580-7.
[53] Maitra RK, Li G, Xiao W, Dong B, Torrence PF, Silverman RH. Catalytic cleavage of an RNA target by 2-5A antisense and RNase L. J Biol Chem. 1995;270(25):15071-5.
[54] Liu Y, Samuel CE. Mechanism of interferon action: functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase. J Virol. 1996;70(3):1961-8.
[55] Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci U S A. 1996;93(8):3636-41.
[56] Burfeind P, Chernicky CL, Rininsland F, Ilan J, Ilan J. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci U S A. 1996;93(14):7263-8.